MAPT and Alzheimer disease: Numerous imaging techniques—like MRI, amyloid-PET, FDG-PET, and tau-PET—coupled with AI-based diagnostic tools have tremendous advantages in terms of the most appropriate diagnosis and prognostication during the early stages of AD, like MCI or the preclinical stages.